MIRA INFORM REPORT

 

 

Report No. :

353798

Report Date :

11.12.2015

 

IDENTIFICATION DETAILS

 

Name :

SANOFI AVENTIS DE COLOMBIA SA

 

 

Registered Office :

Transversal 23 No. 97-73, Piso 9, Ed. City Business Bogota, Bogota D.C.

 

 

Country :

Colombia

 

 

Financials (as on) :

2013

 

 

Date of Incorporation :

24.10.1995

 

 

Legal Form :

Sociedad Anonima

 

 

Line of Business :

Provide pharmaceutical products and services

 

 

No. of Employee :

850

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good 

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Colombia

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

COLOMBIA - ECONOMIC OVERVIEW

 

Colombia's consistently sound economic policies and aggressive promotion of free trade agreements in recent years have bolstered its ability to weather external shocks. Real GDP has grown more than 4% per year for the past four years, continuing almost a decade of strong economic performance. All three major ratings agencies have upgraded Colombia's government debt to investment grade, which helped to attract record levels of investment in 2013 and 2014, mostly in the hydrocarbons sector. Colombia depends heavily on energy and mining exports, making it vulnerable to a drop in commodity prices. Colombia is the world's fourth largest coal exporter and Latin America's fourth largest oil producer. Economic development is stymied by inadequate infrastructure, inequality, poverty, narco-trafficking and an uncertain security situation. Moreover, the unemployment rate of 9.2% in 2014 is still one of Latin America's highest. The SANTOS Administration's foreign policy has focused on bolstering Colombia's commercial ties and boosting investment at home. Colombia has signed or is negotiating Free Trade Agreements (FTA) with more than a dozen countries; the US-Colombia FTA went into force on May 2012. Colombia is also a founding member of the Pacific Alliance - a regional grouping formed in 2012 by Chile, Colombia, Mexico, and Peru to promote regional trade and economic integration. In 2013, Colombia began its ascension process to the OECD. In 2014, Colombia passed a tax reform bill to offset the lost revenue from the global drop in oil prices. The SANTOS administration is also using tax reform to help finance implementation of a peace deal, in the event FARC and the government reach an agreement in 2015. Colombian officials estimate a peace deal may bolster economic growth by almost 2%.

 

Source : CIA

REGISTERED NAME & COMPANY SUMMARY

 

IDENTIFICATION

Comments on data supplied:

The address provided is a branch of the company.

Legal Name:

SANOFI AVENTIS DE COLOMBIA SA

Trade Name:

SANOFI AVENTIS PHARMA SA

Legal Address

Transversal 23 No. 97-73, piso 9

Ed. City Business

Postal Town

Bogota

Post Code

N.A.

Primary Geographic Area

Bogota D.C.

Country

CO

Operative Address

Transversal 23 No. 97-73, piso 9,

Ed. City Business, Bogota, Bogota D.C.

Colombia

Telephone:

+57-1-6214400

NIT :

830.010.337-0

Fax:

+57-1-7444232

Legal Form:

Sociedad Anonima

Email:

info@sanofi-aventis.com

Registered in:

CO

Website:

www.sanofi-aventis.com

Date Created:

1995

Manager:

General Manager BOTERO CAICEDO MAURICIO

Date Incorporated:

October 24th 1995

Staff:

850

Stock:

N.A

 

 

Value:

N.A

Activity:

Provide pharmaceutical products and services.

 

 

DIRECTORS/MANAGEMENT

 

Management:

 

Martha Castro

Communications Manager

 

XIMENA CASTELLANOS ABONDANO

LEGAL REPRESENTATIVE

 

Deifan Ramirez Lopez

Head of Procurement Colombia Ecuador & Peru en Sanofi Aventis

 

 

General Manager

BOTERO CAICEDO MAURICIO

C.C. 16693562

 

CUBIDES BALLESTEROS JESUS HERNANDO        

C.C. 79306514

Manager

 

SALAZAR ARIAS RICARDO EMILIO              

C.C. 79687456 

Manager

 

 

PUERTA PEŃUELA MARIA FERNANDA             

C.C. 52646649 

Manager

 

 

NEGATIVE INFORMATION

 

Legal Filings

 The sources consulted record no detrimental legal or labor court information.

 

 

SHARE & SHARE CAPITAL INFORMATION

 

Shareholders

Listed at the stock exchange:

 

NO

Shareholders Parent Company(ies):

 

Sanofi-Aventis de Colombia SA operates as a subsidiary of Sanofi.

Sanofi S.A. is a multinational pharmaceutical company headquartered in Paris, France, as of 2014 the world's fifth-largest by prescription sales.

The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011.

 

 

PAYMENT INFORMATION

 

PAYMENTS

 

Regular

 

DEBT COLLECTIONS AND PAYMENTS

Public

NO

Payments

REGULAR

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

RELATED COMPANIES:

 

SANOFI-SYNTHELABO DE COLOMBIA S.A

AVENTIS PASTEUR S.A.

 

 

FINANCIAL INFORMATION

 

FINANCIALS - COMMERCIAL TRENDS AND FORECAST

As a private company the subject does not publish any financial statements.

We have contacted the receptionist who explained us that the person that could help us was not available. She requested us to send an email which we did but we did not have any answer so far.

However our financial sources could provide us with the following data.

Those figures are estimates provided by confidential banking and financial institutions working with the company.

 

Currency

DATE

COP

2013

Turnover

485 830 080

Operating Income

108 322 600

Net Income

63 596 062

Current Assets

240 690 064

Non-Current Assets

0

Net worth

238 939 318

Bank Liabilities

61 885 474

The cash flow is

Good

 

Comments on the financial data: The financial statements are provided to us in local language, and we cannot provide a full translation.
For a better approach we have transcribed the main financial figures above.
IMPORTANT: The financial information for 2013 is expressed in COP thousands.
Despite our long searches we could not find financial information for the year 2014.

 

 

FINANCIAL SUMMARY

 

Profitability

CORRECT

Indebtedness

CONTROLLED

Cash

Good

 

 

FOREIGN EXCHANGE RATES

 

N/a

 

 

ADDITIONAL INFORMATION

 

GEOPOLITICS - COLOMBIA

POLITICAL DATA

ECONOMIC DATA

Form of Government: Republic

Economic Risk: Low

Currency: 100.00 COP = 0.0304819 USD

Branch Situation: Stable

 

 

BANKS

 

Name of the Bank

Banco de Bogota

Account Number

Confidential

Comments

This information was not verified by the company.

 

 

BUSINESS HISTORY

 

SANOFI AVENTIS DE COLOMBIA S.A. was created in 1995.

 

November 2015.

The Commercial and Industrial Superintendence stable a fine of USD 517 000 to three pharmaceutical companies since they did not respect the maximum price of 17 products.

 

March 2013;

Acquisition of Genfar SA, a national leader in generics, Sanofi expanded its presence in the country with 2 manufacturing plants, one in Villarica, Cauca and a smaller dedicated to antibiotics in Bogotá.

 

 

PRINCIPAL ACTIVITY

 

SANOFI AVENTIS DE COLOMBIA S.A. is a private company that operates as pharmaceutical products distributors.

Products/Services description:

This company offers 350 products for therapeutic areas such as, oncology, diabetes, internal medicine, central, vaccines and generic nervous system.

Sales are:

Wholesale

Brands:

ALERBUL SANOFI-SYNTHELABO

Clients:

Their clients are retailers and distributors related to the pharmaceutical market; also we found that one of their clients is the local government.

Suppliers:

We could not find suppliers for the subject.

Operations area:

National, International, Local

The company exports to Argentina, Chile, Ecuador, Peru, Uruguay, Venezuela and Panama

Trade References:

Despite our research we could not get information about local suppliers to confirm the trade references.

The subject employs 850 employee(s)

Comments on staff:

The number of employees was not verified by the company.

 

 

LOCATION

 

Headquarters

 

Transversal 23 No. 97-73, piso 9,

Ed. City Business, Bogota, Bogota D.C.

Colombia

Branches:

 

The company has the following branches:

 

Calle 93b # 17-25/49 Bogota, Bogota, Colombia

 

Cr 51B 76-136 L-407 Altos del Prado

Ciudad:Barranquilla (Atlántico, Colombia)

Teléfono: (+57 5) 356 2934

 

CRA 9 NO 30-29,

CALI

VALLE DEL CAUCA

COLOMBIA

 

 

NOTES & COMMENTS

 

 

 Final Opinion

 

SANOFI AVENTIS DE COLOMBIA S.A. is a private company that operates as pharmaceutical products distributors.

 

This company operates with about 850 employees. This means it is a big size company.

 

Sanofi-Aventis de Colombia SA operates as a subsidiary of Sanofi.

 

Sanofi S.A. is a multinational pharmaceutical company headquartered in Paris, France, as of 2014 the world's fifth-largest by prescription sales.

 

After our research and based on the information obtained we suggest a credit line for USD 2 000 000.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.66.79

UK Pound

1

Rs.101.37

Euro

1

Rs.73.46

COP

1

Rs. 0.021

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ASH

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.